OrbiMed Capital GP VII LLC's Net Worth
$384 Million
Who is OrbiMed Capital GP VII LLC?
OrbiMed Capital GP VII LLC has an estimated net worth of $384 Million. This is based on reported shares across multiple companies, which include Keros Therapeutics, Inc., Fusion Pharmaceuticals Inc., Repare Therapeutics Inc., Arcutis Biotherapeutics, Inc., Theseus Pharmaceuticals, Inc., Kinnate Biopharma Inc., Sierra Oncology, Inc., Synthorx, Inc., Terns Pharmaceuticals, Inc., Galecto, Inc., Passage BIO, Inc., Enliven Therapeutics, Inc., Janux Therapeutics, Inc., Third Harmonic Bio, Inc., and Pandion Therapeutics Holdco LLC.
SEC CIK
OrbiMed Capital GP VII LLC's CIK is 0001760648
Past Insider Trading and Trends
2020 was OrbiMed Capital GP VII LLC's most active year for acquiring shares with 36 total transactions. OrbiMed Capital GP VII LLC's most active month to acquire stocks was the month of December. 2023 was OrbiMed Capital GP VII LLC's most active year for disposing of shares, totalling 37 transactions. OrbiMed Capital GP VII LLC's most active month to dispose stocks was the month of March. 2020 saw OrbiMed Capital GP VII LLC paying a total of $106,373,691.00 for 30,545,108 shares, this is the most they've acquired in one year. In 2022 OrbiMed Capital GP VII LLC cashed out on 17,526,737 shares for a total of $133,513,360.13, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Keros Therapeutics, Inc. (KROS) Snapshot price: $52.27
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +170.39% | 1.27M |
$16.00 | $6,003,200.00 | 2.01M |
Apr 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Fusion Pharmaceuticals Inc. (FUSN) Snapshot price: $11.8
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 3.12M |
$17.00 | $3,265,700.00 | 3.12M |
Jun 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Repare Therapeutics Inc. (RPTX) Snapshot price: $7.85
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.12% | -8.08K |
$33.97 | -$274,793.91 | 6.55M |
Scheduled
|
Sep 3 - Sep 7
| ||
Form 4
| -0.38% | -37.86K |
$34.05 | -$1,290,550.08 | 9.89M |
Scheduled
|
Aug 31 - Sep 2
| ||
Form 4
| -0.18% | -18.07K |
$34.13 | -$615,747.82 | 9.98M |
Scheduled
|
Aug 26 - Aug 30
| ||
Form 4
| -0.18% | -18.21K |
$34.16 | -$622,426.25 | 10.03M |
Scheduled
|
Aug 23 - Aug 25
| ||
Form 4
| -0.30% | -20.33K |
$34.06 | -$693,210.46 | 6.71M |
Scheduled
|
Aug 17 - Aug 18
| ||
Form 4
|
∞
| 3.38M |
$20.00 | $1,984,000.00 | 3.38M |
Jun 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Arcutis Biotherapeutics, Inc. (ARQT) Snapshot price: $5.745
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -7.97% | -341.97K |
$21.31 | -$7,287,402.01 | 3.95M |
Jun 24
| |||
Form 4
| -6.06% | -878.20K |
$20.69 | -$18,163,608.12 | 13.62M |
Apr 6 - Apr 8
| |||
Form 4
| +10.61% | 496K |
$25.00 | $12,400,000.00 | 5.17M |
Oct 2
| |||
Form 4
| +836.28% | 4.67M |
$17.00 | $9,501,096.00 | 5.23M |
Feb 3 - Feb 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Theseus Pharmaceuticals, Inc. (THRX) Snapshot price: $4.1
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -17.71M |
—
|
—
|
0
|
Feb 14
| |||
Form 4
| +2.78% | 479.93K |
$3.05 | $1,463,792.60 | 17.71M |
Jul 17
| |||
Form 4
| +1.16% | 192K |
$5.21 | $1,000,320.00 | 16.73M |
Nov 7
| |||
Form 4
| +0.97% | 158.42K |
$9.97 | $1,578,717.49 | 16.54M |
Jan 19 - Jan 21
| |||
Form 4
| +0.27% | 44.72K |
$9.90 | $442,750.42 | 16.38M |
Jan 11 - Jan 13
| |||
Form 4
|
∞
| 16.84M |
$16.00 |
—
| 16.84M |
Oct 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |